Answers are grounded in this paper and cite their sources.
Patients with COPD and other lung diseases are treated with long-term oxygen therapy (LTOT). Portable oxygen sources are required to administer LTOT while maintaining patient autonomy. Existing portable oxygen equipment has limitations that can hinder patient mobility. A novel nasal interface is presented in this study, aiming to enhance breath detection and triggering efficiency of portable pulsed-flow oxygen devices, thereby improving patient mobility and independence.
No takes yet. Share an insight, caveat, or question.
Christianson et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: